• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

保乳手术治疗导管原位癌的女性中,切缘宽度是否会影响乳腺癌复发率?

Does margin width impact breast cancer recurrence rates in women with breast conserving surgery for ductal carcinoma in situ?

机构信息

Division of Surgical Oncology, Department of Surgery, University of Wisconsin, 600 Highland Ave, Madison, WI, 53792, USA.

Department of Population Health Sciences and Carbone Cancer Center, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, USA.

出版信息

Breast Cancer Res Treat. 2021 Sep;189(2):463-470. doi: 10.1007/s10549-021-06278-5. Epub 2021 Jun 15.

DOI:10.1007/s10549-021-06278-5
PMID:34129117
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11098112/
Abstract

PURPOSE

Controversy remains regarding the optimal margin width for patients with ductal carcinoma in situ (DCIS) who undergo breast conserving surgery (BCS).

METHODS

Women with a primary DCIS diagnosis were enrolled in a statewide population-based cohort from 1997 to 2006. Patients were surveyed every two years with follow-up data available through 2016. Surgical pathology reports were collected for 559 participants following breast conserving surgery. Multivariable Cox proportional hazard models evaluated relationships between locoregional recurrence (LRR) and margin width in the presence or absence of adjuvant radiation therapy while controlling for age, menopausal status and duration of endocrine therapy use.

RESULTS

The majority of women in this study were over 50yo (74%), 34% had high grade disease, and 77% underwent radiation. The overall LRR rate was 12%. A LRR occurred in 46 women who had radiation (11%) and 23 women who did not undergo radiation (19%). Univariate analysis identified smaller margin width, younger age, premenopausal status, no radiotherapy, and shorter endocrine therapy use associated with LRR. Multivariable models demonstrated that close margins (< 2 mm) were associated with an increased risk of recurrence when compared to margins ≥ 2 mm in width whether women received radiation (HR 1.98 CI 0.87-4.54) or not (HR 1.32 CI 0.27-6.49), but confidence intervals were wide.

CONCLUSIONS

In this study, patients with DCIS and close margins were less likely to experience recurrence after routine re-excision to margins greater than 2 mm.

摘要

目的

对于接受保乳手术(BCS)的导管原位癌(DCIS)患者,最佳切缘宽度仍存在争议。

方法

1997 年至 2006 年,在全州范围内的人群中招募了患有原发性 DCIS 诊断的女性患者。每两年对患者进行一次调查,随访数据可获得至 2016 年。对 559 名接受保乳手术后的患者进行了外科病理报告的收集。在存在或不存在辅助放疗的情况下,多变量 Cox 比例风险模型评估了局部区域复发(LRR)与切缘宽度之间的关系,同时控制了年龄、绝经状态和内分泌治疗使用时间。

结果

本研究中的大多数女性年龄在 50 岁以上(74%),34%的患者疾病分级较高,77%的患者接受了放疗。总体 LRR 率为 12%。在接受放疗的 46 名女性(11%)和未接受放疗的 23 名女性(19%)中发生了 LRR。单变量分析确定了较小的切缘宽度、较年轻的年龄、绝经前状态、未接受放疗和较短的内分泌治疗时间与 LRR 相关。多变量模型表明,与宽度≥2mm 的切缘相比,近距离(<2mm)切缘与接受或不接受放疗的女性的复发风险增加相关(HR 1.98 CI 0.87-4.54 和 HR 1.32 CI 0.27-6.49),但置信区间较宽。

结论

在这项研究中,DCIS 患者在常规再次切除至大于 2mm 的切缘后,复发的可能性较小。

相似文献

1
Does margin width impact breast cancer recurrence rates in women with breast conserving surgery for ductal carcinoma in situ?保乳手术治疗导管原位癌的女性中,切缘宽度是否会影响乳腺癌复发率?
Breast Cancer Res Treat. 2021 Sep;189(2):463-470. doi: 10.1007/s10549-021-06278-5. Epub 2021 Jun 15.
2
Ductal Carcinoma In Situ and Margins <2 mm: Contemporary Outcomes With Breast Conservation.导管原位癌和切缘<2mm:保乳治疗的当代结果。
Ann Surg. 2019 Jan;269(1):150-157. doi: 10.1097/SLA.0000000000002439.
3
Relationship Between Margin Width and Recurrence of Ductal Carcinoma In Situ: Analysis of 2996 Women Treated With Breast-conserving Surgery for 30 Years.导管原位癌切缘宽度与复发的关系:对2996例行保乳手术治疗30年的女性患者的分析
Ann Surg. 2015 Oct;262(4):623-31. doi: 10.1097/SLA.0000000000001454.
4
Margin width and local recurrence after breast conserving surgery for ductal carcinoma in situ.导管原位癌保乳手术后的切缘宽度与局部复发
Eur J Surg Oncol. 2017 Nov;43(11):2029-2035. doi: 10.1016/j.ejso.2017.08.003. Epub 2017 Sep 4.
5
Decreasing Recurrence Rates for Ductal Carcinoma In Situ: Analysis of 2996 Women Treated with Breast-Conserving Surgery Over 30 Years.降低导管原位癌的复发率:对30年间接受保乳手术的2996名女性的分析。
Ann Surg Oncol. 2015 Oct;22(10):3273-81. doi: 10.1245/s10434-015-4740-8. Epub 2015 Jul 28.
6
Margins in breast cancer: How much is enough?乳腺癌的切缘:多少才算足够?
Cancer. 2018 Apr 1;124(7):1335-1341. doi: 10.1002/cncr.31221. Epub 2018 Jan 16.
7
Impact of Age on Locoregional and Distant Recurrence After Mastectomy for Ductal Carcinoma In Situ With or Without Microinvasion.年龄对伴或不伴微浸润的导管原位癌行乳房切除术患者的局部区域和远处复发的影响。
Ann Surg Oncol. 2019 Dec;26(13):4264-4271. doi: 10.1245/s10434-019-07693-1. Epub 2019 Aug 22.
8
Surgical margins and risk of locoregional recurrence in invasive breast cancer: an analysis of 10-year data from the Breast Cancer Treatment Quality Assurance Project.手术切缘与浸润性乳腺癌局部区域复发风险:来自乳腺癌治疗质量保证项目 10 年数据分析。
Breast. 2013 Oct;22(5):839-44. doi: 10.1016/j.breast.2013.02.018. Epub 2013 Mar 22.
9
Surgical outcomes and prognosis of HER2+ invasive breast cancer patients with a DCIS component treated with breast-conserving surgery after neoadjuvant systemic therapy.新辅助全身治疗后保乳手术治疗伴有 DCIS 成分的 HER2+浸润性乳腺癌患者的手术结果和预后。
Eur J Surg Oncol. 2024 Sep;50(9):108465. doi: 10.1016/j.ejso.2024.108465. Epub 2024 Jun 4.
10
Association of DCIS size and margin status with risk of developing breast cancer post-treatment: multinational, pooled cohort study.DCIS 大小和边缘状态与治疗后乳腺癌发病风险的关系:多国、汇总队列研究。
BMJ. 2023 Oct 30;383:e076022. doi: 10.1136/bmj-2023-076022.

引用本文的文献

1
Aptamer-based NIR II imaging for breast cancer surgical resection.基于适体的近红外二区成像用于乳腺癌手术切除
Npj Imaging. 2025 Aug 19;3(1):38. doi: 10.1038/s44303-025-00095-x.
2
The effects of adjuvant endocrine therapy on long-term outcomes from ductal carcinoma in situ: a systematic review and meta-analysis.辅助内分泌治疗对导管原位癌长期预后的影响:一项系统评价和荟萃分析。
Breast. 2025 Jun 18;82:104521. doi: 10.1016/j.breast.2025.104521.
3
Impact of resection margin width on local recurrence following breast-conserving surgery and whole breast radiotherapy for pure ductal carcinoma in situ: a systematic review and meta-analysis.

本文引用的文献

1
Bridging the rural-urban divide: A commentary on Rural-Urban Commuting Area codes.弥合城乡差距:关于城乡通勤区号的评论
J Rural Health. 2025 Jan;41(1):e12911. doi: 10.1111/jrh.12911.
2
The COMET (Comparison of Operative versus Monitoring and Endocrine Therapy) trial: a phase III randomised controlled clinical trial for low-risk ductal carcinoma in situ (DCIS).COMET(手术与监测和内分泌治疗比较)试验:一项针对低危导管原位癌(DCIS)的 III 期随机对照临床试验。
BMJ Open. 2019 Mar 12;9(3):e026797. doi: 10.1136/bmjopen-2018-026797.
3
Breast-conserving therapy for primary Ductal Carcinoma in Situ in The Netherlands: A multi-center study and population-based analysis.
保乳手术联合全乳放疗治疗单纯导管原位癌时切缘宽度对局部复发的影响:一项系统评价和荟萃分析
BMJ Oncol. 2025 Mar 6;4(1):e000633. doi: 10.1136/bmjonc-2024-000633. eCollection 2025.
4
Management of Ductal Carcinoma In Situ: An Ontario Health (Cancer Care Ontario) Clinical Practice Guideline.导管原位癌的管理:安大略省卫生厅(安大略癌症护理)临床实践指南
Curr Oncol. 2024 Dec 3;31(12):7738-7753. doi: 10.3390/curroncol31120569.
5
Tailored radiation dose according to margin width for patients with ductal carcinoma in situ after breast-conserving surgery.保乳手术后乳腺原位癌患者根据切缘宽度定制放射剂量。
Sci Rep. 2024 Jan 3;14(1):300. doi: 10.1038/s41598-023-50840-8.
荷兰原发性导管原位癌的保乳治疗:一项多中心研究和基于人群的分析。
Breast. 2018 Dec;42:3-9. doi: 10.1016/j.breast.2018.07.007. Epub 2018 Jul 18.
4
Breast Specimen Processing and Reporting With an Emphasis on Margin Evaluation: A College of American Pathologists Survey of 866 Laboratories.乳腺标本处理和报告,重点评估切缘:美国病理学家学院对 866 家实验室的调查。
Arch Pathol Lab Med. 2018 Apr;142(4):496-506. doi: 10.5858/arpa.2016-0626-CP. Epub 2018 Jan 12.
5
Cancer statistics, 2018.癌症统计数据,2018 年。
CA Cancer J Clin. 2018 Jan;68(1):7-30. doi: 10.3322/caac.21442. Epub 2018 Jan 4.
6
20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years.内分泌治疗5年后停药的乳腺癌20年复发风险
N Engl J Med. 2017 Nov 9;377(19):1836-1846. doi: 10.1056/NEJMoa1701830.
7
Evaluating the efficacy of post-surgery adjuvant therapies used for ductal carcinoma patients: a network meta-analysis.评估用于导管癌患者的术后辅助治疗的疗效:一项网状Meta分析。
Oncotarget. 2017 Apr 21;8(45):79257-79269. doi: 10.18632/oncotarget.17366. eCollection 2017 Oct 3.
8
Ductal Carcinoma In Situ and Margins <2 mm: Contemporary Outcomes With Breast Conservation.导管原位癌和切缘<2mm:保乳治疗的当代结果。
Ann Surg. 2019 Jan;269(1):150-157. doi: 10.1097/SLA.0000000000002439.
9
Society of Surgical Oncology-American Society for Radiation Oncology-American Society of Clinical Oncology Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation in Ductal Carcinoma In Situ.外科肿瘤学会-美国放射肿瘤学会-美国临床肿瘤学会关于导管原位癌保乳手术联合全乳照射切缘的共识指南。
J Clin Oncol. 2016 Nov 20;34(33):4040-4046. doi: 10.1200/JCO.2016.68.3573. Epub 2016 Oct 31.
10
The Association of Surgical Margins and Local Recurrence in Women with Ductal Carcinoma In Situ Treated with Breast-Conserving Therapy: A Meta-Analysis.保乳治疗的导管原位癌女性患者手术切缘与局部复发的相关性:一项荟萃分析
Ann Surg Oncol. 2016 Nov;23(12):3811-3821. doi: 10.1245/s10434-016-5446-2. Epub 2016 Aug 15.